EU-4534,
flurfamide,
flurofamide,
N-(diaminophosphinyl)-4-fluorobenzamide,
Flurofamide,
70788-28-2,
Flurfamide,
EU-4534,
N-(Diaminophosphinyl)-4-fluorobenzamide,
Flurofamida [Spanish],
Flurofamine,
Flurofamide [USAN:INN],
Flurofamidum [INN-Latin],
Flurofamida [INN-Spanish],
UNII-599XHU06GH,
NSC 342995,
N-(Diaminophosphinyl)-p-fluorobenzamide,
599XHU06GH,
BENZAMIDE, N-(DIAMINOPHOSPHINYL)-4-FLUORO-,
NSC342995,
NCGC00024609-01,
DSSTox_CID_25654,
DSSTox_RID_81032,
DSSTox_GSID_45654,
Flurofamida,
Flurofamidum,
CAS-70788-28-2,
C7H9FN3O2P,
Tocris-0478,
AC1L1ALG,
Flurofamide (USAN/INN),
SCHEMBL635029,
CHEMBL144620,
DTXSID2045654,
CHEBI:93179,
CTK8F9834,
HMS3264I06,
HMS3266E04,
HMS3675O11,
Pharmakon1600-01502264,
ZINC8036004,
Tox21_110912,
BN0661,
N-diaminophosphoryl-4-fluorobenzamide,
NSC760097,
AKOS024458342,
N-diaminophosphoryl-4-fluoro-benzamide,
Tox21_110912_1,
FCH1328437,
N-(4-Fluorobenzoyl)phosphoric triamide,
NSC-342995,
NSC-760097,
N-(diaminophosphoryl)-4-fluorobenzamide,
NCGC00024609-02,
LS-26298,
B5005,
D04234,
BENZAMIDE,N-(DIAMINOPHOSPHINYL)-4-FLUORO-,
SR-01000597660,
SR-01000597660-1,
BRD-K67445247-001-01-3,
N- -4-FLUOROBENZAMIDE,
C7-H9-F-N3-O2-P,
CID51173,